⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 1, 2024Journal of the American Academy of DermatologyOpen Access

53117 Lower Total IgE After Dupilumab Treatment is Associated With a Reduction in Flares in Patients With Moderate-to-Severe Atopic Dermatitis

Brian Kim Lisa A. Beck Eric L. Simpson Lawrence F. Eichenfield Jonathan I. Silverberg Kilian Eyerich Shinichi Imafuku Zhen Chen Ana B. Rossi Sonya Cyr

View Full Paper

Ask AI

Bookmark

Share

Abstract

Background: Previous reports show that dupilumab treatment reduces IgE levels in patients with moderate-to-severe atopic dermatitis (AD). This analysis reports the impact of dupilumab-induced reduction in total IgE levels on flare probability in patients with moderate-to-severe AD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e59e8eb6db643587538867 https://doi.org/10.1016/j.jaad.2024.07.250

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Progressive Decline in Total IgE and <i>Malassezia</i> -Specific IgE Among Early Dupilumab Recipients With Atopic Dermatitis2025
2Progressive Decline in Total IgE and <i>Malassezia</i> -Specific IgE Among Early Dupilumab Recipients With Atopic Dermatitis2025
3Dupilumab Treatment in Adults with Moderate-to-Severe Atopic DermatitisRCT · 2014 · 1,422 citations
4Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis2024 · 19 citations
5Clinical efficacy of Dupilumab in the treatment of moderate to severe Atopic Dermatitis and Type-II Inflammation-Related comorbidities: A real-world study2025 · 1 citations